Addus HomeCare Co. (NASDAQ:ADUS) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Addus HomeCare Co. (NASDAQ:ADUS) have been assigned an average recommendation of “Moderate Buy” from the eight analysts that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $127.57.

Several research analysts have recently weighed in on the company. Macquarie assumed coverage on Addus HomeCare in a research report on Friday, June 28th. They issued an “outperform” rating and a $136.00 price objective for the company. Stephens reissued an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a research report on Tuesday, August 6th. StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Oppenheimer lifted their price objective on Addus HomeCare from $130.00 to $140.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 7th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $141.00 price objective on shares of Addus HomeCare in a research report on Tuesday, September 3rd.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. The disclosure for this sale can be found here. In the last quarter, insiders sold 22,917 shares of company stock worth $3,050,082. Insiders own 4.60% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Hedge funds and other institutional investors have recently modified their holdings of the business. Principal Securities Inc. purchased a new position in Addus HomeCare in the fourth quarter valued at approximately $26,000. UMB Bank n.a. lifted its stake in Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after purchasing an additional 88 shares during the last quarter. Quest Partners LLC purchased a new position in Addus HomeCare in the second quarter valued at approximately $31,000. EntryPoint Capital LLC purchased a new position in Addus HomeCare in the first quarter valued at approximately $44,000. Finally, Innealta Capital LLC purchased a new position in Addus HomeCare in the second quarter valued at approximately $44,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Trading Down 2.0 %

Shares of ADUS opened at $130.44 on Monday. The company has a market capitalization of $2.36 billion, a PE ratio of 32.37, a PEG ratio of 2.33 and a beta of 1.04. Addus HomeCare has a 12 month low of $78.35 and a 12 month high of $136.12. The stock’s 50-day moving average price is $127.07 and its two-hundred day moving average price is $114.28.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 5th. The company reported $1.35 EPS for the quarter, topping the consensus estimate of $1.21 by $0.14. The firm had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.94 EPS. Equities research analysts predict that Addus HomeCare will post 4.58 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.